Researchers have identified two UK children who have a geneticmutation equivalent to that seen in the ob/ob mouse. The two children have low levels of leptin, in contrast to many obese people who have normal or elevated levels of the ob gene product. Meantime, a group of US researchers has identified a second mutation, in the gene for prohormone convertase-1, which is involved in the production of many metabolic hormones. Reported in Nature and Nature Genetics respectively, these are the first reported instances of a genetic basis for human obesity.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze